A dissected non-ribosomal peptide synthetase maintains activity.
Dopamine
Drosophila
Mass spectrometry (MS)
Natural product biosynthesis
Non-ribosomal peptide synthetase
Peptide biosynthesis
Protein-protein interaction
Synthetase dissection
Journal
Biochimica et biophysica acta. Proteins and proteomics
ISSN: 1878-1454
Titre abrégé: Biochim Biophys Acta Proteins Proteom
Pays: Netherlands
ID NLM: 101731734
Informations de publication
Date de publication:
01 Jan 2024
01 Jan 2024
Historique:
received:
08
09
2023
revised:
25
10
2023
accepted:
02
11
2023
pubmed:
12
11
2023
medline:
12
11
2023
entrez:
11
11
2023
Statut:
ppublish
Résumé
Non-ribosomal peptide synthetases (NRPSs) generate chemically complex compounds and their modular architecture suggests that changing their domain organization can predictably alter their products. Ebony, a small three-domain NRPS, catalyzes the formation of β-alanine containing amides from biogenic amines. To examine the necessity of interdomain interactions, we modeled and docked domains of Ebony to reveal potential interfaces between them. Testing the same domain combinations in vitro showed that 8 % of activity was preserved after Ebony was dissected into a di-domain and a detached C-terminal domain, suggesting that sufficient interaction was maintained after dissection. Our work creates a model to identify domain interfaces necessary for catalysis, an important step toward utilizing Ebony as a combinatorial engineering platform for novel amides.
Identifiants
pubmed: 37951518
pii: S1570-9639(23)00086-9
doi: 10.1016/j.bbapap.2023.140972
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
140972Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joris Beld reports financial support was provided by Commonwealth Universal Research Enhancement (CURE) grant.